Metrics as of 10/17/2026, 07:38 AM (Berlin time), refresh in progress.
Shoulder Innovations Stock
Shoulder Innovations, Inc.
Company data
- Sector
- Healthcare
- Industry
- Medical - Specialties
- Country
- United States
- CEO
- Robert Joseph Ball
- Employees
- 74
- Market cap
- $377 M
- IPO
- 31/07/2025
Shoulder Innovations, Inc. manufactures medical devices. It has developed a shoulder replacement system. The company was founded by Stephen B. Gunther and Michael DeVries in 2009 and is headquartered in Grand Rapids, MI.
Shoulder Innovations stock: price history
1D
-1.5%
1W
-0.2%
1M
+1.1%
6M
+20.6%
YTD
+26.5%
1Y
+47.1%
2Y
–
5Y
–
10Y
–
Next earnings date
Next earnings date
No date known
Volatility around earnings
~78% stronger price swings than usual
Shoulder Innovations stock scores
- Valuation
Visible after free registration
- Trend
Visible after free registration
- Quality
Visible after free registration
- Dividend
Visible after free registration
- Growth
Visible after free registration
- Insider
Visible after free registration
- Earnings
Visible after free registration
- Revisions
Visible after free registration
- Sentiment
Visible after free registration
- Short Pressure
Visible after free registration
Register for free
Unlock all 11 scores
- 5 credits free on registration
- Access to virtual portfolios and watchlist
- No credit card, no payment details needed
- No subscription, no minimum term
- Our own servers in Germany, no US cloud
Deterministically calculated from financial metrics, not investment advice. Updated nightly, last on 16/10/2026.
Business model & megatrends
Very robust business model with strong megatrend tailwind: wide moat, strong pricing power, predictable revenue.
Shoulder Innovations, Inc. is a specialized medical device manufacturer focused on a proprietary shoulder replacement system. The business model encompasses the development and production of surgical equipment and implants. Through specialization in this medical segment, the company generates revenue through the sale of hardware components to medical facilities.
- Revenue model
- Hardware sales
- Recurring revenue
- High
- Pricing power
- Moderate
- Moat
- Narrow
- Moat type
- Regulatory
- Capital intensity
- Medium
- Customer concentration
- Unknown
Ask the agents about Shoulder Innovations
Analyst assessment of Shoulder Innovations
PRICE TARGET LOW
US$19.00
CONSENSUS
US$24.67
MEDIAN
US$27.00
PRICE TARGET HIGH
US$28.00
0
STRONG BUY
4
BUY
0
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 12/10/2026
Shoulder Innovations stock metrics
P/E
-10.58
P/B
3.02
EV/EBITDA
-11.51
RETURN ON EQUITY
-8.2%
NET MARGIN
-59.1%
DEBT/EQUITY
0.12
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
Free float & liquidity
FREE FLOAT
87.4%
FLOAT SHARES
18,194,473
AVG. DAILY VOLUME (30D)
125,155
Insider transactions (SEC)
Sidow Kevin K.
Hykes Andrew
Tansey Casey M
BUCKMAN PAUL
Ball Robert Joseph
Attention
1 mention today in US forums, about the same as yesterdayPrice since yesterday: -1.5%
Search (Google Trends)
Forums (Reddit)
Institutional holders
Comparable stocks
Frequently asked questions about Shoulder Innovations stock
What does Shoulder Innovations do?
Shoulder Innovations, Inc. is a company in the Healthcare sector, Medical - Specialties industry, headquartered in United States.
The CEO is Robert Joseph Ball, the company employs around 74 people.
The IPO was on 31/07/2025; the stock trades on NYSE under the ticker SI.
What do analysts say about Shoulder Innovations stock?
4 analysts rate the stock, the consensus is Buy (as of 12/10/2026).
The average price target is US$24.67, ranging from US$19.00 to US$28.00, with a median of US$27.00.
This is an external assessment, not a statement by Market Jury.
When does Shoulder Innovations report next?
Around past earnings, price swings were roughly 78% stronger than usual.
Does Shoulder Innovations pay a dividend?
No, Shoulder Innovations currently does not pay a dividend.
Which stocks are comparable to Shoulder Innovations?
Comparable stocks include STERIS, QuidelOrtho, Mesa Laboratories, 908 Devices, Trinity Biotech, Eli Lilly and Company, Johnson & Johnson and AbbVie.
How can I get Shoulder Innovations stock analyzed?
Clicking "Analyze stock" lets five strategies assess Shoulder Innovations against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.